Statements (16)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:biotechnology
|
| gptkbp:country |
gptkb:Spain
|
| gptkbp:developedBy |
siRNA-based drugs
|
| gptkbp:focusesOn |
ophthalmology
pain management RNA interference therapeutics |
| gptkbp:foundedYear |
2006
|
| gptkbp:headquartersLocation |
gptkb:Madrid,_Spain
|
| https://www.w3.org/2000/01/rdf-schema#label |
Sylentis
|
| gptkbp:industry |
gptkb:biotechnology
|
| gptkbp:notableProduct |
SYL040012
SYL1001 |
| gptkbp:parentCompany |
PharmaMar Group
|
| gptkbp:website |
https://www.sylentis.com/
|
| gptkbp:bfsParent |
gptkb:PharmaMar
|
| gptkbp:bfsLayer |
7
|